Microneedling with creams for patchy hair loss
Treatments studied
Part of Skin clinical trials.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older
- You have one or more bald patches on your scalp, each no bigger than 6 cm (about 2.4 inches) across
- You have not used any hair loss treatments (pills or creams) in the last 3 months
- You are not pregnant or breastfeeding
- You are willing to attend several visits and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new topical cream for people with patchy alopecia areata (a type of hair loss). It aims to help regrow hair without using stronger medicines.
This study tests whether a new drug called LY4005130 can help regrow hair in adults with severe alopecia areata (an autoimmune condition causing patchy or widespread hair loss). The trial is looking for people who have lost a significant amount of hair and haven't seen it grow back on its own for at least 6 months.
This trial compares two injections—triamcinolone (a steroid) and candida albicans antigen (a yeast extract)—to see which works better for alopecia areata (patchy hair loss). You might benefit if you have mild to moderate hair loss and haven't used other treatments recently.
This study compares a cream (calcipotriol) with a steroid injection to treat patchy hair loss from alopecia areata. It aims to find which works better for people with mild to moderate scalp hair loss.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.